Harvard Bioscience, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 2.92 M | $7.84 M | 100.00% | 6.69% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 11/14/2024 | 2.77 M | $7.46 M | 0.01% | 6.36% |
| HARVEY PARTNERS, LLC | 11/14/2024 | 2.72 M | $7.30 M | 6.16% | 6.23% |
| AMH EQUITY LTD | 11/07/2024 | 2.39 M | $6.43 M | 8.59% | 5.48% |
| VANGUARD GROUP INC | 11/13/2024 | 2.15 M | $5.79 M | 1.71% | 4.94% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 1.87 M | $5.02 M | -3.11% | 4.28% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 1.72 M | $4.62 M | -6.12% | 3.93% |
| B. RILEY ASSET MANAGEMENT, LLC | 12/05/2024 | 1.54 M | $4.13 M | 0.00% | 3.52% |
| ROYCE & ASSOCIATES LP | 11/06/2024 | 1.45 M | $3.90 M | 0.69% | 3.33% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 1.34 M | $3.59 M | 0.00% | 3.06% |
| HEARTLAND ADVISORS INC | 11/12/2024 | 1.20 M | $3.23 M | 0.00% | 2.75% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 912,599 | $2.46 M | 2.24% | 2.09% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 873,614 | $2.35 M | -9.29% | 2.00% |
| MEROS INVESTMENT MANAGEMENT, LP | 11/18/2024 | 833,589 | $2.24 M | -0.19% | 1.91% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 724,078 | $1.95 M | -2.84% | 1.66% |
| STATE STREET CORP | 11/14/2024 | 717,387 | $1.93 M | 1.09% | 1.64% |
| ACUITAS INVESTMENTS, LLC | 11/07/2024 | 491,092 | $1.32 M | 20.56% | 1.13% |
| BARD ASSOCIATES INC | 11/06/2024 | 312,399 | $840,354 | 5.19% | 0.72% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 301,225 | $810,294 | -28.79% | 0.69% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 239,696 | $644,782 | 0.00% | 0.55% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 230,077 | $618,907 | -16.22% | 0.53% |
| GREENWOOD CAPITAL ASSOCIATES LLC | 10/30/2024 | 225,866 | $607,580 | 9.15% | 0.52% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 202,315 | $544,227 | -11.15% | 0.46% |
| PASADENA PRIVATE WEALTH, LLC | 11/08/2024 | 198,039 | $532,725 | 0.00% | 0.45% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 184,500 | $496,305 | 0.00% | 0.42% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 180,006 | $484,216 | 19.69% | 0.41% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 175,424 | $471,890 | 125.38% | 0.40% |
| STRS OHIO | 11/01/2024 | 163,000 | $438,470 | 5.84% | 0.37% |
| MORGAN STANLEY | 11/14/2024 | 160,349 | $431,338 | 142.97% | 0.37% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 139,999 | $376,597 | 0.00% | 0.32% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/14/2024 | 128,536 | $345,762 | -59.85% | 0.29% |
| CITADEL ADVISORS LLC | 11/14/2024 | 115,994 | $312,024 | -7.48% | 0.27% |
| CLARIVEST ASSET MANAGEMENT LLC | 11/12/2024 | 114,271 | $325,672 | 0.00% | 0.26% |
| RIVERWATER PARTNERS LLC | 10/22/2024 | 103,414 | $264,740 | -2.42% | 0.24% |
| PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 94,768 | $254,926 | 100.00% | 0.22% |
| GABELLI FUNDS LLC | 11/13/2024 | 60,000 | $161,400 | 33.33% | 0.14% |
| BARCLAYS PLC | 11/19/2024 | 58,655 | $157,000 | 304.38% | 0.13% |
| WINTON GROUP LTD | 11/12/2024 | 54,559 | $146,764 | -14.63% | 0.13% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 39,956 | $107,482 | -47.19% | 0.09% |
| RHUMBLINE ADVISERS | 11/12/2024 | 38,727 | $104,169 | -18.90% | 0.09% |
| LEGATO CAPITAL MANAGEMENT LLC | 11/07/2024 | 36,425 | $97,984 | 0.00% | 0.08% |
| VERITION FUND MANAGEMENT LLC | 11/14/2024 | 34,015 | $91,500 | -11.21% | 0.08% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 33,706 | $90,669 | -43.09% | 0.08% |
| JPMORGAN CHASE & CO | 12/26/2024 | 29,501 | $79,358 | 62.95% | 0.07% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 26,935 | $72,455 | 4.14% | 0.06% |
| BRIGHTON JONES LLC | 10/22/2024 | 25,365 | $68,232 | 100.00% | 0.06% |
| ADVANTAGE ALPHA CAPITAL PARTNERS LP | 11/13/2024 | 23,617 | $63,530 | 100.00% | 0.05% |
| CORSAIR CAPITAL MANAGEMENT, L.P. | 11/13/2024 | 23,362 | $62,844 | 100.00% | 0.05% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 23,322 | $62,736 | 10.26% | 0.05% |
| JANE STREET GROUP, LLC | 11/15/2024 | 23,002 | $61,875 | -61.89% | 0.05% |
Harvard Bioscience, Inc.institutional Ownership - FAQ's
During the previous two years, 128 institutional investors and hedge funds held shares of Harvard Bioscience, Inc.. The most heavily invested institutionals were:
BlackRock Funding, Inc. /DE: 2.92 M
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.: 2.77 M
Harvey Partners, LLC: 2.72 M
AMH Equity Ltd: 2.39 M
VANGUARD GROUP INC: 2.15 M
Granahan Investment Management, LLC: 1.87 M
71.74% of Harvard Bioscience, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 38.01 M shares in the last 24 months. This purchase volume represents approximately $73.36 M in transactions.